Genomtec (FRA:4VI) Tariff Resilience Score: 0/10 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4VI Genomtec SA FRA:4VI
38 GF Score
Price €0.95
GF Value €0.41
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Genomtec Tariff Resilience Score?

Genomtec has the Tariff Resilience Score of 0, which implies that the company might have .

Genomtec has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Genomtec might have .

Genomtec  (FRA:4VI) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Genomtec Tariff Resilience Score Related Terms

FRA:4VI
38GF Score
Genomtec SA FRA:4VI
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genomtec (FRA:4VI) Overvalued in 2026?

Based on GuruFocus' analysis, Genomtec stock appears to be overvalued. The current stock price of €0.95 is trading 130.7% above its estimated GF Value™ of €0.41. GuruFocus considers Genomtec to be Significantly Overvalued.

Key valuation signals for FRA:4VI:

  • Tariff Resilience Score: 0
  • GF Value™: €0.41 vs. price of €0.95 (130.7% above fair value)
  • GF Score™: 38/100 with 4 warning signs

No single metric tells the full story. See the FRA:4VI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genomtec Business Description

Other Exchanges GMT:Poland
Address ul. Stablowicka 147, PORT Building 2, Wroclaw, POL, 54-066
Genomtec SA is an technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.
38GF Score

Get the complete analysis for FRA:4VI

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.95
Price
€0.41
GF Value